MetaVia Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

MetaVia Stock Summary

MetaVia competes with Lisata Therapeutics, NuCana PLC, Exicure, Enlivex Therapeutics, and Klotho Neurosciences,. MetaVia is entity of United States. It is traded as Stock on NASDAQ exchange.

MetaVia Key Financial Ratios

MetaVia Key Balance Sheet Accounts

MetaVia Key Cash Accounts

MetaVia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MetaVia's current stock value. Our valuation model uses many indicators to compare MetaVia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MetaVia competition to find correlations between indicators driving MetaVia's intrinsic value. More Info.MetaVia is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, MetaVia's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MetaVia's earnings, one of the primary drivers of an investment's value.

MetaVia Systematic Risk

Today, most investors in MetaVia Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MetaVia's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MetaVia growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of MetaVia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MetaVia. We use our internally-developed statistical techniques to arrive at the intrinsic value of MetaVia based on widely used predictive technical indicators. In general, we focus on analyzing MetaVia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MetaVia's daily price indicators and compare them against related drivers.

When running MetaVia's price analysis, check to measure MetaVia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaVia is operating at the current time. Most of MetaVia's value examination focuses on studying past and present price action to predict the probability of MetaVia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaVia's price. Additionally, you may evaluate how the addition of MetaVia to your portfolios can decrease your overall portfolio volatility.